A 22-year-old woman presents to a Pune tertiary-care hospital reporting a suspected drug-facilitated sexual assault from the previous evening. The casualty collects the standard DFC kit within the 22-hour window: a 30 mL urine sample, a chain-of-custody-sealed serum vial, and the BSA 2023 Section 63 medico-legal request form. The case is forwarded to the state FSL toxicology unit at Hadapsar.
The screening bench runs a TLC presumptive on a 10 microlitre aliquot of acidified-and-extracted urine. The plate is a 10 by 10 cm silica gel 60 F254 plate, developed with ethyl acetate, methanol and ammonia in 80:10:10 ratio over a 7 cm migration distance. After drying, the plate is visualised under UV-254 for fluorescence quenching, then sprayed with Dragendorff reagent (bismuth subnitrate, potassium iodide, glacial acetic acid in water). A bright orange spot appears at Rf 0.45, exactly matching the alprazolam reference standard spotted on the same plate. The bench logs a presumptive positive for alprazolam and triggers the confirmatory workflow.
The confirmatory bench takes a fresh 1 mL aliquot of the urine, spikes 10 ng/mL d5-alprazolam internal standard before extraction, and runs solid-phase extraction on a mixed-mode cation-exchange cartridge. The extract is dried under nitrogen and reconstituted in 200 microlitres of 95:5 water-acetonitrile with 0.1 percent formic acid.
The injection goes onto an Agilent 6470 LC-MS/MS triple-quad with an electrospray-positive source. The chromatographic method is a 6-minute gradient from 5 percent acetonitrile to 95 percent acetonitrile in 0.1 percent formic acid water on a 2.1 by 50 mm C18 sub-2-micrometre column at 0.4 mL/min and 40 degrees Celsius. The MRM method monitors alprazolam at 309 to 281 (quantifier, collision energy 28 eV) and 309 to 205 (qualifier, 38 eV), with d5-alprazolam at 314 to 286 (28 eV). The scheduled MRM window is 1 minute wide, centred on the expected retention time of 4.20 minutes.
The calibration curve runs at 0.5, 1, 2, 5, 10, 25 and 50 ng/mL alprazolam in matrix-matched blank urine, each spiked with 10 ng/mL d5-alprazolam. The analyte-to-IS area ratio versus concentration line gives an R-squared of 0.9997. The LOD by 3-sigma on seven blank replicates is 0.1 ng/mL and the LOQ by 10-sigma is 0.5 ng/mL.
The case sample reads at 12 ng/mL alprazolam. The retention time is 4.18 minutes, within 0.5 percent of the standard. The quantifier-to-qualifier intensity ratio is 100 to 78 against the reference-standard ratio of 100 to 75, well inside the plus-or-minus 20 percent tolerance. The d5-alprazolam IS area in the case sample is 94 percent of the calibrator IS area, indicating modest matrix suppression that the IS correction handles cleanly. The Cerilliant alprazolam CRM in the batch reads 9.8 ng/mL against its certified 10.0 ng/mL.